Abstract
While the combination of nifurtimox and eflornithine (NECT) is currently recommended for the treatment of the late stage human African trypansomiasis (HAT), single-agent eflornithine was still the treatment of choice when this trial commenced. This study intended to provide supportive evidence to complement previous trials. A multi-centre randomised, open-label, non-inferiority trial was carried out in the Trypanosoma brucei gambiense endemic districts of North-Western Uganda to compare the efficacy and safety of NECT (200 mg/kg eflornithine infusions every 12 h for 7 days and 8 hourly oral nifurtimox at 5 mg/kg for 10 days) to the standard eflornithine regimen (6 hourly at 100 mg/kg for 14 days). The primary endpoint was the cure rate, determined as the proportion of patients alive and without laboratory signs of infection at 18 months post-treatment, with no demonstrated trypanosomes in the cerebrospinal fluid (CSF), blood or lymph node aspirates, and CSF white blood cell count < 20 /μl. The non-inferiority margin was set at 10%. One hundred and nine patients were enrolled; all contributed to the intent-to-treat (ITT), modified intent-to-treat (mITT) and safety populations, while 105 constituted the per-protocol population (P...Continue Reading
References
Feb 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·D LegrosD Mbulamberi
May 3, 2000·Lancet·C BurriR Brun
May 12, 2001·Tropical Medicine & International Health : TM & IH·A Stanghellini, T Josenando
May 12, 2001·Tropical Medicine & International Health : TM & IH·E MatovuR Kaminsky
May 12, 2001·Tropical Medicine & International Health : TM & IH·C Burri, J Keiser
Sep 1, 2004·Lancet·C SchmidC Burri
Dec 13, 2006·PLoS Clinical Trials·Gerardo PriottoPatrice Piola
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gerardo PriottoUnni Karunakara
Dec 7, 2007·PLoS Neglected Tropical Diseases·Francesco ChecchiGerardo Priotto
Feb 16, 2008·Parasites & Vectors·Dietmar Steverding
May 30, 2008·Emerging Infectious Diseases·Jo RobaysMarleen Boelaert
Mar 26, 2009·The Journal of Antimicrobial Chemotherapy·Magnus UnemoJohn Tapsall
Jun 30, 2009·Lancet·Gerardo PriottoVictor Kande
Nov 26, 2009·PLoS Neglected Tropical Diseases·Philippe BüscherSylvain Biéler
Oct 18, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emilie AlirolFrançois Chappuis
Nov 13, 2012·PLoS Neglected Tropical Diseases·Pere P SimarroJean G Jannin
Dec 5, 2012·PLoS Neglected Tropical Diseases·Caecilia SchmidOlaf Valverde Mordt
Sep 11, 2014·Expert Review of Anti-infective Therapy·Gilles EperonFrançois Chappuis
Citations
Aug 29, 2018·ChemMedChem·Gregorio CulliaAndrea Pinto
Feb 13, 2020·Parasitology·Claudio A PereiraEdward Valera-Vera
Feb 11, 2020·Current Pharmaceutical Design·Vasiliki PardaliGrigoris Zoidis
Jun 23, 2020·ChemMedChem·Santina MaioranaMaria Zappalà
Feb 6, 2020·Frontiers in Cellular and Infection Microbiology·Nathan Michael ChasenRonald Drew Etheridge
Jun 20, 2020·MSphere·Nathan Michael ChasenRonald Drew Etheridge
Jan 23, 2020·Tropical Medicine and Infectious Disease·Harry P De Koning
Apr 7, 2020·Drug Development Research·Fernando AltamuraIgor Cestari
May 16, 2019·Cancer Research·Meghan TraversCynthia A Zahnow
May 22, 2020·ACS Medicinal Chemistry Letters·Roberta EttariMaria Zappalà
Feb 3, 2021·Infection and Immunity·Adwaita R Parab, Laura-Isobel McCall
Jun 19, 2021·Frontiers in Molecular Biosciences·Satabdi Datta Choudhury
Dec 7, 2018·Chemical Reviews·Yih Ching OngGilles Gasser
Nov 13, 2019·Journal of Medicinal Chemistry·Roberta EttariMaria Zappalà
Nov 9, 2021·PLoS Neglected Tropical Diseases·Andrea KuemmerleOlaf Valverde Mordt
Dec 10, 2021·The Cochrane Database of Systematic Reviews·Vittoria LutjeGemma Villanueva